Option Care Health (OPCH) to Release Earnings on Tuesday

Option Care Health (NASDAQ:OPCH) is set to release its earnings data before the market opens on Tuesday, April 23rd. Analysts expect Option Care Health to post earnings of $0.23 per share for the quarter. Option Care Health has set its FY 2024 guidance at EPS.Persons interested in participating in the company’s earnings conference call can do so using this link.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Thursday, February 22nd. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. The firm had revenue of $1.12 billion for the quarter, compared to analyst estimates of $1.09 billion. Option Care Health had a return on equity of 18.78% and a net margin of 6.21%. Option Care Health’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.26 earnings per share. On average, analysts expect Option Care Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $30.91 on Tuesday. The business’s 50 day moving average price is $32.37 and its 200 day moving average price is $31.61. The firm has a market cap of $5.37 billion, a P/E ratio of 21.03, a P/E/G ratio of 1.73 and a beta of 1.22. Option Care Health has a 52 week low of $24.23 and a 52 week high of $35.74. The company has a quick ratio of 1.33, a current ratio of 1.77 and a debt-to-equity ratio of 0.74.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the firm’s stock in a transaction on Monday, February 26th. The stock was bought at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the acquisition, the director now owns 269,528 shares of the company’s stock, valued at approximately $8,503,608.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. BlackRock Inc. increased its position in shares of Option Care Health by 8.5% during the first quarter. BlackRock Inc. now owns 21,444,169 shares of the company’s stock worth $681,281,000 after purchasing an additional 1,671,783 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Option Care Health by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 19,626,205 shares of the company’s stock worth $661,207,000 after purchasing an additional 306,853 shares in the last quarter. State Street Corp increased its position in shares of Option Care Health by 1.0% during the second quarter. State Street Corp now owns 5,497,168 shares of the company’s stock worth $178,603,000 after purchasing an additional 52,404 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Option Care Health by 11.9% during the first quarter. Geode Capital Management LLC now owns 3,271,566 shares of the company’s stock worth $103,938,000 after purchasing an additional 346,958 shares in the last quarter. Finally, Bellevue Group AG increased its position in shares of Option Care Health by 10.6% during the first quarter. Bellevue Group AG now owns 3,232,787 shares of the company’s stock worth $92,328,000 after purchasing an additional 308,744 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

OPCH has been the topic of a number of recent research reports. Jefferies Financial Group upped their target price on Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research report on Monday, March 4th. Barrington Research boosted their price target on Option Care Health from $35.00 to $38.00 and gave the company an “outperform” rating in a report on Friday, February 23rd.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.